Answer
As a precaution, it is preferable to avoid lanadelumab during pregnancy because there are no or limited data on its use in pregnant women.
Sources for this answer
- TAKHZYRO 300 mg solution for injection in pre-filled syringeTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked